- Home
- RVPH vs FTHM Comparison
RVPH vs FTHM Comparison
Compare RVPH & FTHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- FTHM
- Stock Information
- Founded
- RVPH 2006
- FTHM 2010
- Country
- RVPH United States
- FTHM United States
- Employees
- RVPH N/A
- FTHM N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- FTHM Real Estate
- Sector
- RVPH Health Care
- FTHM Finance
- Exchange
- RVPH Nasdaq
- FTHM Nasdaq
- Market Cap
- RVPH 36.7M
- FTHM 33.6M
- IPO Year
- RVPH N/A
- FTHM 2020
- Fundamental
- Price
- RVPH $0.70
- FTHM $1.06
- Analyst Decision
- RVPH Strong Buy
- FTHM Buy
- Analyst Count
- RVPH 5
- FTHM 1
- Target Price
- RVPH $9.00
- FTHM $2.50
- AVG Volume (30 Days)
- RVPH 662.3K
- FTHM 61.8K
- Earning Date
- RVPH 08-13-2025
- FTHM 08-11-2025
- Dividend Yield
- RVPH N/A
- FTHM N/A
- EPS Growth
- RVPH N/A
- FTHM N/A
- EPS
- RVPH N/A
- FTHM N/A
- Revenue
- RVPH N/A
- FTHM $357,816,000.00
- Revenue This Year
- RVPH N/A
- FTHM $32.40
- Revenue Next Year
- RVPH N/A
- FTHM $18.04
- P/E Ratio
- RVPH N/A
- FTHM N/A
- Revenue Growth
- RVPH N/A
- FTHM 5.80
- 52 Week Low
- RVPH $0.49
- FTHM $0.65
- 52 Week High
- RVPH $4.28
- FTHM $3.37
- Technical
- Relative Strength Index (RSI)
- RVPH 39.46
- FTHM 46.00
- Support Level
- RVPH $0.67
- FTHM $1.03
- Resistance Level
- RVPH $0.90
- FTHM $1.36
- Average True Range (ATR)
- RVPH 0.06
- FTHM 0.10
- MACD
- RVPH -0.02
- FTHM -0.03
- Stochastic Oscillator
- RVPH 11.36
- FTHM 13.04
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.